Recent Finacing
Recent Raise
Develops peptide-mimetic small molecules that modulate intercellular protein–protein interactions; advancing lead PRI-724 into clinical trials for fibrosis indications including hepatitis C–associated and idiopathic pulmonary fibrosis.
Recent Investors
Total Raised
Funding round
Investors